Related Experiment Video
Updated: May 24, 2026
08:51
Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
Published on: February 19, 2021
Pediatric multiple sclerosis: what we know and where are we headed?
William S MacAllister1, Christopher Christodoulou, Maria Milazzo
1New York University School of Medicine, Department of Neurology, Comprehensive Epilepsy Center, New York, USA. William.macallister@nyumc.org
Summary
Multiple Sclerosis (MS) is increasingly recognized in pediatric populations. This review covers clinical features, pathology, imaging, and psychosocial aspects of MS in childhood and adolescence.
Area of Science:
- Neurology
- Immunology
- Pediatrics
Background:
- Multiple Sclerosis (MS) traditionally affects young adults.
- Pediatric-onset MS (POMS) is gaining recognition.
- Growing research focuses on MS in younger individuals.
Purpose of the Study:
- To review the literature on Multiple Sclerosis in childhood and adolescence.
- To detail the clinical presentation, neuropathology, and pathogenesis of POMS.
- To discuss MRI findings and neuropsychological/psychosocial factors in pediatric MS.
Main Methods:
- Comprehensive literature review.
- Synthesis of existing research on pediatric MS.
- Analysis of clinical, pathological, and imaging data.
Main Results:
- MS presentation in children and adolescents differs from adult-onset MS.
- Neuropathology and pathogenesis are being elucidated in young patients.
- MRI findings aid in diagnosis and understanding disease progression.
- Neuropsychological and psychosocial impacts are significant.
Conclusions:
- Early-onset MS requires specialized understanding and management.
- Further research is needed to optimize treatment and support for pediatric MS patients.
- Recognizing MS in younger populations is crucial for timely diagnosis and intervention.
Related Concept Videos
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...